These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29053884)

  • 1. Looking into cognitive impairment in primary-progressive multiple sclerosis.
    Petracca M; Sumowski J; Fabian M; Miller A; Lublin F; Inglese M
    Eur J Neurol; 2018 Jan; 25(1):192-195. PubMed ID: 29053884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
    Petracca M; Cordano C; Cellerino M; Button J; Krieger S; Vancea R; Ghassemi R; Farrell C; Miller A; Calabresi PA; Lublin F; Inglese M
    Mult Scler; 2017 Jan; 23(1):43-50. PubMed ID: 26993116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis.
    Esmael A; Elsherif M; Abdelsalam M; Sabry D; Mamdouh M; Belal T
    Neurol Res; 2020 Jul; 42(7):564-574. PubMed ID: 32370626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.
    Stellmann JP; Cetin H; Young KL; Hodecker S; Pöttgen J; Bittersohl D; Hassenstein A; Oberwahrenbrock T; Heesen C; Siemonsen S
    Brain Behav; 2017 Feb; 7(2):e00614. PubMed ID: 28239524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal neurodegeneration and brain MRI markers: the Rotterdam Study.
    Mutlu U; Bonnemaijer PWM; Ikram MA; Colijn JM; Cremers LGM; Buitendijk GHS; Vingerling JR; Niessen WJ; Vernooij MW; Klaver CCW; Ikram MK
    Neurobiol Aging; 2017 Dec; 60():183-191. PubMed ID: 28974335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions.
    Ciampi E; Uribe-San-Martin R; Vásquez M; Ruiz-Tagle A; Labbe T; Cruz JP; Lillo P; Slachevsky A; Reyes D; Reyes A; Cárcamo-Rodríguez C
    Mult Scler Relat Disord; 2018 Feb; 20():122-128. PubMed ID: 29414284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy.
    Ong YT; Hilal S; Cheung CY; Venketasubramanian N; Niessen WJ; Vrooman H; Anuar AR; Chew M; Chen C; Wong TY; Ikram MK
    Neurosci Lett; 2015 Jan; 584():12-6. PubMed ID: 25451722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.
    Ehrhardt H; Lambe J; Moussa H; Vasileiou ES; Kalaitzidis G; Murphy OC; Filippatou AG; Pellegrini N; Douglas M; Davis S; Nagy N; Quiroga A; Hu C; Zambriczki Lee A; Duval A; Fitzgerald KC; Prince JL; Calabresi PA; Sotirchos ES; Bermel R; Saidha S
    Neurology; 2023 Sep; 101(10):e1014-e1024. PubMed ID: 37460235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
    Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
    JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.
    Winges KM; Murchison CF; Bourdette DN; Spain RI
    Mult Scler; 2019 Jan; 25(1):55-62. PubMed ID: 29111873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
    Cagol A; Fuertes NC; Stoessel M; Barakovic M; Schaedelin S; D'Souza M; Würfel J; Brandt AU; Kappos L; Sprenger T; Naegelin Y; Kuhle J; Granziera C; Papadopoulou A
    J Neurol; 2023 Apr; 270(4):2139-2148. PubMed ID: 36625888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
    Zivadinov R; Bergsland N; Cappellani R; Hagemeier J; Melia R; Carl E; Dwyer MG; Lincoff N; Weinstock-Guttman B; Ramanathan M
    Eur J Neurol; 2014 Aug; 21(8):1137-e61. PubMed ID: 24779967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.
    Coric D; Balk LJ; Verrijp M; Eijlers A; Schoonheim MM; Killestein J; Uitdehaag BM; Petzold A
    Mult Scler; 2018 Feb; 24(2):158-166. PubMed ID: 28273785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in retinal neurodegeneration as a surrogate marker for cortical atrophy in multiple sclerosis.
    Lichtman-Mikol S; Razmjou S; Yarraguntla K; Bao F; Santiago-Martinez C; Seraji-Bozorgzad N; Bernitsas E
    Mult Scler Relat Disord; 2019 Jun; 31():141-147. PubMed ID: 30991300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal thinning and brain atrophy in early MS and CIS.
    Borgström M; Tisell A; Link H; Wilhelm E; Lundberg P; Huang-Link Y
    Acta Neurol Scand; 2020 Nov; 142(5):418-427. PubMed ID: 32416627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.